Contents
Contents
Medicare fraud statistics count different things: payment errors, alleged bills, settlements and money recovered. For someone working in billing, pharmacy operations or payment review, the useful question is where the money went. A claim submitted, a payment stopped and a refund received tell different stories. The records on your desk may show the part a headline leaves out.
The Centers for Medicare & Medicaid Services measures payment accuracy. The Justice Department reports alleged schemes and civil resolutions. Collections reports follow money received. Adding their totals together would count overlapping work as fresh money.
Medicare spending reached $1,210.1 billion on the trust-fund cash basis in calendar 2025, including administration, according to the 2026 Trustees Report. Its $530.9 billion in Part C benefit payments was already inside the Medicare accounts. Adding Medicare Advantage again counts the same benefit money twice.
A prescription’s pharmacy price and the government’s final drug bill answer different questions. Rebates and later payment adjustments change what Medicare ultimately pays.
Improper-payment estimates measure payment accuracy. They include documentation failures, coding errors, medical-necessity findings and underpayments. Each rate applies to the payments examined for that part of Medicare.
For fiscal 2025, the Centers for Medicare & Medicaid Services reported a 6.55% fee-for-service improper-payment rate, or $28.83 billion. Its fee-for-service report covers claims submitted from July 1, 2023, through June 30, 2024.
The Part C estimate was 6.09%, or $23.67 billion, for payment year 2023. This measures Medicare Advantage payments, which vary with the diagnoses used to describe a patient’s health.
The Part D estimate was 4.00%, or $4.23 billion, for calendar 2023 payments.
Gross error counts money paid too high and money paid too low in the same total. Net error subtracts the underpayments.
Documentation problems, medical-necessity findings and coding errors contribute to fee-for-service improper payments. The Part D results give a particularly clear example: 75.00% of sampled errors involved missing or invalid documentation. Drug and pricing discrepancies made up the other categories.
The people behind these measurements do different work. Medicare contractors process claims, review payments and investigate suspected schemes, while the Comprehensive Error Rate Testing program estimates national fee-for-service payment error. A targeted investigation and a national sample answer different questions.
The Centers for Medicare & Medicaid Services’ adjusted historical series puts the fee-for-service error rate at 12.09% in fiscal 2015 and 7.66% in fiscal 2024.
Medicare Advantage and Part D have changed their measurement methods too. Those changes affect comparisons over time.
In Operation Gold Rush, the criminal indictment alleged approximately $10.6 billion in false Medicare claims. The Justice Department’s account described a network buying medical supply companies and using stolen beneficiary identities to bill for urinary catheters and other durable medical equipment.
The Justice Department’s account of the payment intervention describes approximately $4.45 billion scheduled for Medicare payment. The HHS Office of Inspector General and the Centers for Medicare & Medicaid Services prevented the organization from receiving all but approximately $41 million. The same account reports approximately $900 million paid by Medicare supplemental insurers. The payer changes the loss figure as much as the payment stage does.
We see both the scale of the alleged scheme and the value of stopping payment. Calling the entire bill a loss would erase what the intervention accomplished.
Stopped money remains unpaid. Returned money has reached its recipient. Gold Rush shows why the distinction matters.
In its June 30, 2025 announcement, the Justice Department said the Department of Health and Human Services and the Centers for Medicare & Medicaid Services intended to seek the return of $4.41 billion held in escrow to the Medicare trust fund.
For an insider, the alleged scheme also shows why stolen Medicare identities matter beyond a suspicious bill. The beneficiary information supplied the raw material for claims through businesses that could bill the program. The claim, the business controlling it and the account receiving payment are connected parts of the same inquiry.
A civil settlement states what the company agreed to pay to resolve allegations. A collection records money received. Earlier refunds can already be part of the settlement total.
Elixir resolved allegations that it falsely reported Part D rebates. Its 2024 agreement stated a $121 million package comprising $101 million in fixed payments and a $20 million claim payable through the bankruptcy. That last portion was a claim against the estate, not cash in hand.
Medicare uses reported rebates to adjust its Part D payments. A false rebate report can leave taxpayers paying too much even after the prescription has been filled.
DaVita Rx’s December 2017 civil resolution totaled $63.7 million, including approximately $22.2 million previously repaid. Adding the earlier refunds again would count them twice.
Walgreens’ September 2024 announcement concerned allegations that it billed for prescriptions never dispensed. Across the resolutions, the federal recovery share was $91,881,530 and the state share was $14,933,259. The Part D agreement separately recorded $66,314,790 in prior refunds within its payment terms.
A Medicare and Medicaid settlement needs those payer allocations.
A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. The reward follows the recovery, with its own stated amount and allocation.
Kaiser Permanente’s January 2026 settlement announcement put the civil settlement at $556 million and the announced whistleblower share at $95 million. The government alleged that Kaiser pressured physicians to add unsupported diagnoses to increase Medicare Advantage payments and ignored internal warnings. Former employees brought the whistleblower cases.
For an employee who knows why the diagnoses changed or why warnings went unanswered, the case also shows how knowledge inside the business can matter.
Agency totals describe the work of the reporting agency and the recipients it tracks. They overlap when the same matter involves CMS, the HHS Office of Inspector General and the Justice Department.
The Health Care Fraud and Abuse Control Program’s fiscal 2023 report separates Medicare trust-fund transfers from other federal receipts and whistleblower payments.
The HHS Office of Inspector General also reports investigative receivables: money ordered or agreed payable. That is an amount due, rather than a collection.
The Centers for Medicare & Medicaid Services’ May 2026 account of fiscal 2025 integrity work estimated $41.9 billion in savings, with 68% attributed to cost avoidance. The agency estimated a return of $22.3 for every $1 spent on Medicare program integrity. Those savings combine avoided payments, recoveries and other actions. Calling all of it cash recovered would turn prevention into a collection that never happened.
CMS administers payment controls. The HHS Office of Inspector General and the Federal Bureau of Investigation investigate, and the Justice Department pursues cases.
The billing patterns behind these cases range from phantom billing for undelivered supplies to upcoding that inflates the service billed, medically unnecessary treatment and kickbacks for referrals. Prescription fraud can reach drugs billed but never dispensed, while stolen identities supply information used on false claims.
The answer changes with the measure: alleged billing, civil settlement or money paid. Gold Rush illustrates the scale of alleged billing and prevention. Kaiser illustrates a large civil settlement involving Medicare Advantage. National health care fraud takedowns combine cases involving Medicare, Medicaid and private insurers.
A ranking by alleged claims would answer a different question from a ranking by civil settlements. We care about what the number says happened to the money. Biggest is not a payment status.
In Medicare Home Health Fraud: How Much, Where, and Who?, a 2026 National Bureau of Economic Research working paper, the researchers estimated that 3.4% of Medicare home-health spending in 2008, about $520 million, was billed by agencies their method classified as fraudulent.
The study defined fraudulent agencies by federal strike-force prosecutions. Its description of those home health agencies gives an insider something more useful than a national total:
Fraudulent HHAs display intuitive characteristics: they are more likely to rely on extremely high-volume referring physicians, to exhibit unusually uniform patterns of care, and to serve healthier-than-average patients.
Medicare Home Health Fraud: How Much, Where, and Who?, National Bureau of Economic Research, 2026
The study combined claims with prosecution records from nine federal judicial districts where strike forces operated between 2009 and 2013. It then modeled the likelihood of prosecution elsewhere had a strike force been present.
The Congressional Research Service’s 2011 Medicare Program Integrity report described the underlying pressure: rapid claims payment followed by efforts to chase improper money. That payment system helps explain why billing records and later enforcement outcomes tell different parts of the story.
Detection studies address another task. Multivariate Anomaly Detection in Medicare Using Model Residuals and Probabilistic Programming, published in the 2017 Florida Artificial Intelligence Research Society conference proceedings, describes a model that prioritizes unusual provider payments for further investigation. Its useful output is where to look next.
Charge counts and billing outliers do not establish a comparable state fraud rate. They reflect where investigators worked, which providers they examined and what their measures counted. The home-health study itself used the presence of strike forces to model how prosecution might differ elsewhere.
An employee’s knowledge is more specific than a state ranking. Orders, claims, payment records and internal warnings connect the apparent pattern to decisions inside a business.
If you work with Medicare claims, payment reviews or pharmacy accounts and know why the figures tell different stories, speak with our whistleblower experts about the transactions behind them. We help you build your strongest Medicare whistleblower case from the money, the records and the decisions, and bring in Medicare fraud whistleblower lawyers with the expertise your case needs. We stay with you through the case, including the questions the spreadsheets cannot answer.